baber/WOPTO huggingface dataset:
Patent MX-2020012738-A (MX)
Title: System and method for controlling an automated braking application.
Inventor: MILLER JR THOMAS S
IPC: B60T8/26
Filed: 2019-05-31
Abstract: A controller is configured to receive a signal representing a requested system brake application and an identified urgency. A hardware processor is capable of: determining a maximum braking pressure to be applied during the system braking application based on the identified urgency; generating a first system brake mode control signal, based on the determined maximum braking pressure, to set an associated first valve to a first valve state; generating a second system brake mode control signal, based on the determined maximum braking pressure, to set an associated second valve to a second valve state, the maximum braking pressure during the system braking application being set by the first valve state and the second valve state; determining an activation profile based on the determined maximum braking pressure; the controller transmitting the first and second system brake mode control signals and modulator control signals according to the activation profile.
Patent MX-2021001553-A (MX)
Title: Novel mutations that enhance the dna cleavage activity of acidaminococcus sp. cpf1.
Inventor: ZHANG LIYANG
IPC: C12N9/22
Filed: 2019-08-08
Abstract: The present disclosure concerns polynucleotides and amino acids of<i> Acidaminococcus</i> <i>sp</i>. Casl2a (Cpfl) and methods for their use for genome editing in eukaryotic cells.
Patent MX-2021004418-A (MX)
Title: 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament.
Inventor: WIEDENMAYER DIETER
IPC: C07D405/10
Filed: 2019-10-16
Abstract: The present invention relates to novel 4-pyrazin-2-ylmethyl-morpholines of general formula A, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an asso- ciation with NR2B negative allosteric modulating properties.
Patent MX-2021006727-A (MX)
Title: Light source for maintaining circadian metrics while allowing flexibility in changing intensity and color temperature.
Inventor: PROTZMAN BRENT
IPC: H05B47/155
Filed: 2019-12-06
Abstract: Methods and systems as described herein may be used for independently controlling the color temperature, intensity, and/or circadian response (CR) of one or more light sources (e.g., discrete-spectrum light sources) to adjust one or more color temperature, intensity, and circadian metrics in a space. For example, a light fixture may have four controllable light sources, a warm CR boost, cool CR boost, warm non-boost CR and a cool non-boost CR to independently control intensity, color temperature, and CR outputs.
Patent MX-2021007939-A (MX)
Title: Claudin18.2 binding moieties and uses thereof.
Inventor: LIU YONG
IPC: A61P35/00
Filed: 2019-12-27
Abstract: Described herein are binding moieties, such as antibodies, that specifically bind Claudin 18.2, and chimeric antigen receptors comprising such binding moieties. Further provided are engineered immune cells (such as T cells) comprising anti-Claudin 18.2 chimeric antigen receptors. Also disclosed are methods of treating Claudin 18.2-expressing tumor or cancers using the binding moieties, chimeric antigen receptors and engineered immune cells.
Patent MX-2021008248-A (MX)
Title: Pharmaceutical composition.
Inventor: ROBERGE CHRISTOPHE
IPC: A61K9/00
Filed: 2020-01-08
Abstract: The present invention provides a pharmaceutical composition comprising: a biodegradable multi-branched copolymer comprising at least three polyester arms attached to a central core which comprises a polyether, and wherein the multi-branched copolymer is substantially insoluble in aqueous solution, further comprising at least one pharmaceutically active ingredient.
Patent MX-2021011673-A (MX)
Title: Long-lasting cleansing foam.
Inventor: SCHMIDT MICHAEL
IPC: C11D1/06
Filed: 2017-07-14
Abstract: The present invention relates to an aqueous foaming cleansing composition for removing dirt at low temperatures from a surface. It characterizes by comprising a C12-alkyl dimethylamine oxide, oxide linear, branched C12-alkyl diethylamine, C12-alkyl methyl-ethylamine oxide, a linear or branched C14-alkyl dimethylamine oxide, C14-alkyl diethylamine oxide, and C14-alkyl methyl-ethylamine oxide. Also, it includes an anionic surfactant of a dodecyl (oxyethylene) w sulfate, where w represents an average number of moles of addition ranging from about one to 10, a polyoxy-alkylene alkyl carboxylic acid ether, or a salt thereof represented by formula (I): RO-(AO)n-1-A'-COOmM (I) where R represents a linear and branched alkyl group having from about eight to 18 carbon atoms, AO represents an oxy alkylene group having from about two to four carbon atoms, n represents an average number of moles of addition ranging from about one to 20, A' represents an alkylene group having from about one to thre e carbon atoms, M represents H or a cation, and m represents the number equal to a valence number of M a source of alkalinity and water.
Patent MX-2021012895-A (MX)
Title: Through-silicon-via fabrication in planar quantum devices.
Inventor: KUMAR ARVIND
IPC: H10N69/00
Filed: 2020-03-20
Abstract: On a first superconducting layer (316) deposited on a first surface of a substrate (312), a first component of a resonator is pattered. On a second superconducting layer (326) deposited on a second surface of the substrate (312), a second component of the resonator is patterned. The first surface and the second surface are disposed relative to each other in a non-co-planar disposition. In the substrate, a recess is created, the recess extending from the first superconducting layer to the second superconducting layer. On an inner surface of the recess, a third superconducting layer (322) is deposited, the third superconducting layer forming a superconducting path between the first superconducting layer and the second superconducting layer. Excess material of the third superconducting layer is removed from the first surface and the second surface, forming a completed through-silicon via TSV (320).
Patent MX-2022000219-A (MX)
Title: Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (rcc) and other cancers.
Inventor: WEINSCHENK TONI
IPC: A61K39/00
Filed: 2017-09-28
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent MX-2022002670-A (MX)
Title: Press fabric for a textured product.
Inventor: BELL JAMES R
IPC: D21F3/00
Filed: 2020-09-09
Abstract: Disclosed is a press fabric and related method to impart a texture to a cellulose product by having macro-voids in a complementary pattern on a sheet-contact side surface of the press fabric.
Patent MX-2022003393-A (MX)
Title: Method and apparatus for over ice brewing.
Inventor: HOLMES ROBERT
IPC: A47J31/40
Filed: 2020-09-17
Abstract: A beverage forming method and system arranged to allow a user to adjust a volume and flow rate of liquid provided to a brew chamber so that a dispensed beverage is suitable for mixing with ice, e.g., to form an iced coffee beverage. In some cases, a user may provide input indicating that an iced beverage should be dispensed during a beverage dispensing operation. For example, after a dispensing operation is started to dispense a beverage having a particular volume, a user can adjust the beverage volume to be smaller and suitable for mixing with ice.
Patent MX-2022004058-A (MX)
Title: Kir3dl3 is an inhibitory receptor of the immune system and uses thereof.
Inventor: ZANG XINGXING
IPC: A61K39/395
Filed: 2020-10-01
Abstract: Described herein are antibodies, immunogenic fragments and compositions thereof targeting the killer-cell immunoglobulin-like receptor protein KIR3DL3, as well as methods of using the same for the treatment of human diseases including cancer. In certain embodiments, the disclosure relates to an antibody or an immunogenic fragment thereof that specifically binds to KIR3DL3 protein, wherein the antibody or the immunogenic fragment thereof specifically binds to a KIR3DL3 epitope comprising the whole extracellular domain or a portion thereof.
Patent MX-2022005559-A (MX)
Title: Bearing system for reciprocating pump and method of assembly.
Inventor: BAYYOUK JACOB A
IPC: B21K1/26
Filed: 2017-01-19
Abstract: A power end frame assembly for a reciprocating pump that includes a first and second end plate segment each including annular bearing support surfaces configured to support a crankshaft bearing assembly. At least one middle plate segment is disposed between the first and second end plate segments and includes an annular bearing support surface configured to support a crankshaft bearing assembly. The annular bearing support surfaces of the first and second end plate segments and the at least one middle plate segment each have a diameter and are coaxially aligned. The diameter of at least one of the first and second end plate segments is different from the diameter of the at least one middle plate segment to facilitate insertion and removal of the crankshaft bearing assembly from the power end frame assembly.
Patent MX-2022005868-A (MX)
Title: Random access for secondary user equipment.
Inventor: ZHANG YU
IPC: H04W74/08
Filed: 2019-11-14
Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a primary user equipment (UE) may transmit, on a sidelink, information indicating a set of sidelink random access configurations corresponding to a set of uplink random access configurations; receive, on the sidelink and from a secondary UE, a random access signal based at least in part on a selected sidelink random access configuration of the set of sidelink random access configurations, wherein the selected sidelink random access configuration corresponds to a selected uplink random access configuration of the set of uplink random access configurations; and selectively performing a random access procedure in accordance with the selected uplink random access configuration. Numerous other aspects are provided.
Patent MX-2022006002-A (MX)
Title: Immunomodulatory fusion proteins and uses thereof.
Inventor: GREENBERG PHILIP D
IPC: A61K35/17
Filed: 2017-08-31
Abstract: The present disclosure relates to immunomodulatory fusion proteins containing an extracellular binding domain and an intracellular signaling domain, wherein binding of a target can generate a modulatory signal in a host cell, such as a T cell. The present disclosure also relates to uses of immune cells expressing such immunomodulatory fusion proteins to treat certain diseases, such as cancer or infectious disease.
Patent MX-2022006269-A (MX)
Title: Bottom part of enclosure for electrical installations.
Inventor: WEBER KENNETH
IPC: H02B1/30
Filed: 2020-11-24
Abstract: The invention relates to a bottom part (1) of an enclosure, comprising a bottom (2) and a locking member to attach a cover (8) to the bottom part To allow the use of the same bottom part (1) with covers (8) of different kinds, and for the bottom part to allow the opening direction of the cover to be changed, the first wall (3) of the bottom part comprises a locking member (30al) which comprises a form-locking piece (7b) which is detachably adapted in a recess in the first wall (3) of the bottom part (1), and a second wall of the bottom part, which is opposite to the first wall, comprises a locking member (40al) which comprises a form-locking piece detachably adapted in a recess in the second wall, whereby the locking member (30al) of the first wall (3) is diametrically located opposite to the locking member (40al) of the second wall, and the form-locking pieces (7b) comprise a planar outer surface which is in the same plane as the outer surface of said walls of the bottom part to which walls the form-locking pieces are adapted, and said walls (3) comprise detents which are adapted to prevent the removal of the form-locking pieces (7b) from the bottom part (1) to a direction away from the plane defined by the bottom of the bottom part (1).
Patent MX-2022007539-A (MX)
Title: Prebiotic and probiotic treatment to reduce oral dysbiosis and promote eubiosis.
Inventor: MIRA OBRADOR ALEJANDRO
IPC: A61K9/00
Filed: 2020-12-16
Abstract: Provided herein is a composition comprising nitrate for use in reducing or preventing oral dysbiosis and/or increasing oral eubiosis, by changing the bacterial composition and functions thereof of oral biofilms in a mammal, by decreasing the amount of disease-associated bacteria and increasing the amount of health-associated bacteria, thereby getting an acute treatment or prevention with effects before 24 hours of a biofilm-mediated oral disease (e.g. caries, periodontal diseases - gingivitis, periodontitis or peri-implantitis - and halitosis), and wherein the composition is orally administered to the mammal and thereby increases the concentration of nitrate in the saliva of the mouth. The composition can also comprise a bacterial strain belonging to Rothia, Neisseria or Kingella genera, for use in increasing the nitrate-reduction capacity of a mammal.
Patent MX-2022007858-A (MX)
Title: Crispr-cas effector polypeptides and methods of use thereof.
Inventor: DOUDNA JENNIFER A
IPC: C07K14/195
Filed: 2020-12-22
Abstract: The present disclosure provides RNA-guided CRISPR-Cas effector proteins, nucleic acids encoding same, and compositions comprising same. The present disclosure provides ribonucleoprotein complexes comprising: an RNA-guided CRISPR-Cas effector protein of the present disclosure; and a guide RNA. The present disclosure provides methods of modifying a target nucleic acid, using an RNA-guided CRISPR-Cas effector protein of the present disclosure and a guide RNA.
Patent MX-2022010368-A (MX)
Title: Rapid dispersing wet wipe.
Inventor: COLE DOUGLAS B
IPC: A61K8/02
Filed: 2019-08-30
Abstract: A cleaning wipe having a nonwoven substrate impregnated with a dispersal composition including at least one of a polar solvent and a water-in-oil emulsion is disclosed. The dispersal composition provides an enhancement to the dispersion of the nonwoven substrate including a binder when placed within a waste water stream after use, thereby more effectively disposing of the wipe after use..
Patent MX-2022010807-A (MX)
Title: Defined composition gene modified t-cell products.
Inventor: JENSEN MICHAEL C
IPC: A61K39/395
Filed: 2016-10-06
Abstract: Aspects of the invention described herein, concern approaches to make genetically modified T-cells comprising a chimeric antigen receptor for human therapy. In some alternatives, the methods utilize a selection and/or isolation of CD4+ and/or CD8+ T-cells from a mixed T-cell population, such as, peripheral blood or apheresis derived mononuclear cells. Once selected/isolated, the CD4+ and/or CD8+ T-cells are then activated, genetically modified, and propagated, preferably, in separate or isolated cultures in the presence of one or more cytokines, which support survival, engraftment and/or proliferation of the cells, as well as, preferably promoting or inducing the retention of cell surface receptors, such as CD62L, CD28, and/or CD27. Included herein are also methods of treatment, inhibition, amelioration, or elimination of a cancer by administering to a subject in need thereof, one or more types of the genetically engineered T-cells or compositions that comprise the genetically engineered T-cell prepared as described herein.
Patent MX-2022013531-A (MX)
Title: Devices to support and position an intraocular lens within the eye and methods of use.
Inventor: CLARKE MATTHEW
IPC: A61F2/16
Filed: 2021-04-28
Abstract: An implantable device for supporting an intraocular lens in an eye including a lens support structure having a central aperture; and one or more fixation arms coupled to the lens support structure and configured to locate and stabilize the device within the eye. Related tools, systems, and methods are provided.
Patent MX-NL03000034-A (MX)
Title: Module for operating shifts.
Inventor: MARTIN E TREVINO VALLEJO
IPC: B60K20/00
Filed: 2003-09-30
Abstract: The present invention results from the need of operating shifts in transmissions that are in engines located at the rear portion of passenger transit type vehicles. Nowadays, a single function is carried out by two mechanisms, thereby provoking the transmissions to have substantial problems and causing troubles to the driver due to the difficulty to operate the shifts, the driver suffering the aforementioned for 8 hours a day.
Patent MX-PA00002707-A (MX)
Inventor: SCHWARTE STEPHAN
IPC: C09D133/06
Filed: 1998-08-29
Abstract: La presente invención se refiere a una dispersión de esmalte claro en polvo, la cual contiene un componente A sólido, pulverulento, y un componente B acuoso, en donde el componente A es un esmalte en polvo que contiene:a) cuando menos un aglutinante que contiene epoxi, con un contenido de 30 a 45%, preferentemente 30 a 35%, de monómeros que contienen glicidilo, eventualmente con un contenido de compuestos vinilaromáticos, preferentemente estireno, b) tris(alcoxicarbonilamino)triacina yácidos policarboxilicos,ácidos dicarboxílicos alifáticos preferentemente de cadena recta y/o poliésteres carboxifuncionales como reticulante, y c) eventualmente catalizadores, auxiliares, aditivos típicos para esmaltes en polvo, tales como desgasificadores, niveladores, absorbedores de UV, captadores de radicales libres, antioxidantes, y el componente B es una dispersión acuosa que contiene:a) cuando menos un espesante no iónico, y b) eventualmente catalizadores, auxiliares, desespumantes, humectores, auxiliares de dispersión, agentes de dispersión preferentemente carboxifuncinales, antioxidantes, absorbentes de UV, captores de radicales libres, biocidas, bajas cantidades de solventes, niveladores, neutralizadores, preferentemente aminas y/o agentes de retención de ag
Patent MX-PA00009639-A (MX)
Title: Ryegrass endophytes.
Inventor: FLETCHER LESTER RONALD
IPC: A01H15/00
Filed: 2000-10-02
Abstract: Selected endophytes of the genus Neotyphodlum (formerly Acremonium) form stable synthetic combinations with ryegrass Hosts (preferably Lolium perenne). The combinations have improved resistance to invertebrate pests and drought effects as compared to ryegrass cultivars not containing such endophytes. The particular combinations of the invention have reduced toxicity to livestock as compared to naturally occurring endophyte/ryegrass combinations. The six preferred endophytes are AR1, AR12, AR22, AR50, AR52 and AB56.
Patent MX-PA00010591-A (MX)
Title: Folding roll-away table.
Inventor: DENNIS GRIEPENTROG
IPC: A47B3/14
Filed: 2000-10-27
Abstract: A folding sectional table assembly includes a pair of table sections, each of which includes a table top and leg structure pivotably mounted to the table top. Each leg structure includes a pair of upper tubular members pivotably mounted between a pair of apron members secured to the underside of the table top, for providing pivoting movement of the leg structure relative to the table top. A torsion bar assist mechanism is disposed within selected ones of the upper tubular members of the leg structures, and includes a torsion bar located within an internal passage defined by the upper tubular member. Each end of the upper tubular member is pivotably mounted to a hub member secured to one of the apron members. One end of the torsion bar is engaged with a torsion bar retainer mounted to one of the hub members, and a torsion bar driver is mounted to the upper tubular member at a location spaced from the torsion bar retainer, and engages the torsion bar to twist the torsion bar during pivo ting movement between the table top and the leg structure. A pneumatic cylinder assembly is interconnected with each table section for cushioning the table sections as the table sections are lowered, and also to provide a spring biased assist in lifting the table sections for folding. At least one pair of hinge plates interconnects the table sections. Each cylinder assembly is interconnected at one end with a hinge pin which pivotably interconnects the hinge plates, and at the other end to one of the leg structures.
Patent MX-PA01000602-A (MX)
Title: Food intake restriction device.
Inventor: FORSELL PETER
IPC: A61B17/12
Filed: 1999-08-12
Abstract: A device for forming a stoma opening in the stomach or esophagus of a patient comprises an elongated restriction member (2), forming means (10) for forming the elongated restriction member into at least a substantially closed loop around the stomach or esophagus, said loop defining a restriction opening (3), and an adjustment means (12) for adjusting the restriction member in said loop to change the size of said restriction opening. The adjustment means (12) is designed to mechanically adjust the restriction member in a non-invasive manner to allow post-operation non-invasive adjustments of the restriction member.
Patent MX-PA01001297-A (MX)
Title: Method and composition for inhibiting cardiovascular cell proliferation.
Inventor: JOHN P COOKE
IPC: A61K38/08
Filed: 2000-06-05
Abstract: Cardiovascular cell proliferation in a blood vessel subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant, can be inhibited by contacting the vessel with a polymer consisting of from 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine, and the polymer contains at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers 7 to 15 subunits in length.
Patent MX-PA01003280-A (MX)
Title: Fluid containing endoluminal stent.
Inventor: EDWIN TARUN
IPC: A61F2/82
Filed: 1999-09-30
Abstract: An endoluminal stent contains a hollow passageway for the circulation of fluids to treat vascular walls affected with malignant growths or experiencing restenosis. The hollow passageway stent can have one or a plurality of passageways and is configured in a tubular shape with numerous coils, providing an empty tubular lumen through the center of the stent to allow blood flow. The stent is connected to a removable catheter that conducts fluid to the stent. Fluid flow may be regulated by valves incorporated in either the stent and/or the catheter. The stent and catheter are connected to avoid leakage of the fluid. Cryogenic, heated or radioactive fluids are circulated through the stent to treat the affected sites. A method of delivering drugs to the vascular wall is also provided by creating a stent with porous outer walls to allow diffusion of the drug.
Patent MX-PA01003489-A (MX)
Title: Air-permeable filter for ink cartridge and ink cartridge comprising same.
Inventor: HIROAKI MASHIKO
IPC: B01D71/26
Filed: 2001-04-05
Abstract: An air-permeable filter for ink cartridge is described, which comprises a laminate comprising at least one porous material layer comprising at least one resin selected from the group consisting of fluororesin and polyolefin resin and at least one air-permeable substrate layer having a tensile strength of 1 MPa or more. An ink cartridge is also described, which comprises a space for receiving an ink and at least one air vent in which the air-permeable filter is provided.